Anna Ponek

Anna Ponek

Auto-generated profile, based on publicly available information

Anna Ponek

Department of Cardiology, Boston Children's Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2025 in Circulation
Verified
Journal Article
Closed access
MSMason E. Sweat
Mason E. Sweat
WSWei Shi
Wei Shi
YSYan Y. Sweat
Yan Y. Sweat
JLJie Li
Jie Li
JLJiajin Li
Jiajin Li
WPWilliam Pu
William Pu
BACKGROUND: Atrial fibrillation, the most common sustained arrhythmia, affects 59 million individuals worldwide. The transcription factor TBX5 (T-box 5) is essential for normal atrial rhythm. Its inactivation causes loss of atrial cardiomyocyte (aCM) enhancer accessibility, looping, transcriptional identity, and spontaneous atrial fibrillation. TBX5 interacts with CHD4 (chromodomain helicase DNA-binding protein 4), a chromatin remodeling ATPase canonically associated with the NuRD (nucleosome remodeling and deacetylase) repressor complex. METHODS: We investigated mechanisms by which TBX5 regulates chromatin organization by studying mice with aCM-selective inactivation of TBX5 or CHD4. We integrated multiple genomics approaches including concurrent single-nucleus transcriptome and open chromatin profiling and genome-wide TBX5 and CHD4 chromatin occupancy assays. RESULTS: We found that TBX5 recruits CHD4 to 33 170 genomic regions (TBX5-enhanced CHD4 sites). In addition to the canonical repressive activity of CHD4, we uncovered a CHD4 activator function predominantly at sites to which it was recruited by TBX5. TBX5-enhanced CHD4 recruitment increased local chromatin accessibility and promoted the expression of aCM identity genes. This mechanism of CHD4 recruitment by TBX5 was crucial for sinus rhythm; mice with CHD4 inactivation in aCMs had increased atrial fibrillation vulnerability. Assaying TBX5 binding in Chd4 AKO atria demonstrated that CHD4 also promotes TBX5 binding at >10 000 genomic loci, including 3051 TBX5-enhanced CHD4 sites. Consistent with its requirement to maintain normal atrial rhythm, CHD4 was implicated in the regulation of 42 genes linked to atrial fibrillation in humans. Nine had the hallmarks of TBX5-dependent, CHD4-mediated transcriptional activation. CONCLUSIONS: Our findings reveal that normal atrial rhythm requires CHD4, which activates and represses atrial genes in a context-dependent manner to maintain aCM gene expression, aCM identity, and atrial rhythm homeostasis.

28 March 2025 in Circulation Research
Verified
Journal Article
Closed access
RPRobin M. Perelli
Robin M. Perelli
EDEnya R. Dewars
Enya R. Dewars
HCHeidi Cope
Heidi Cope
ABAlexander S. Behura
Alexander S. Behura
APAnna Q. Ponek
Anna Q. Ponek
ALAndrew Landstrom
Andrew Landstrom
BACKGROUND: Arrhythmogenic cardiomyopathy (ACM) is one of the leading causes of sudden cardiac death in children, young adults, and athletes and is characterized by the fibro-fatty replacement of the myocardium, predominantly of the right ventricle. Sixty percent of patients with ACM have a known genetic cause, but for the remainder, the pathogenesis is unknown. This lack of mechanistic understanding has slowed the development of disease-modifying therapies, and children with ACM have a high degree of morbidity and mortality. METHODS: Induced pluripotent stem cells (iPSCs) from 3 family members were differentiated into cardiac myocytes (CMs). Calcium imaging was conducted by labeling calcium with CAL-520 and confocal imaging to capture calcium sparks after iPSC-CMs were electrically paced. A cardiac-specific, inducible knockout mouse ( Tax1bp3 −/− ) was made and intracardiac electrophysiology studies conducted to observe arrhythmia inducibility following pacing. RESULTS: We identified a kindred with multiple members affected by ACM cosegregating with biallelic variants in the gene TAX1BP3 , which encodes the protein TAX1BP3 (Tax1-binding protein 3). iPSC-CMs derived from this kindred demonstrated increased intracellular lipid droplets, induction of TRPV4 (transient receptor potential vanilloid type 4) expression, and inducible TRPV4 current. This was associated with depletion of the intracellular sarcoplasmic reticulum Ca 2+ store and increased RyR2 (ryanodine receptor 2)-mediated store Ca 2+ leak and delayed afterdepolarizations, a known mechanism of Ca 2+ -mediated arrhythmogenesis. Similarly, Tax1bp3 cardiac-specific knockout mice had increased Ca 2+ leak and were predisposed to ventricular arrhythmias compared with wild-type mice. Ca 2+ leak in both the iPSC-CMs and mouse ventricular myocytes was rescued by small molecule TRPV4 inhibition. This strategy also effectively reduced Ca 2+ leak in a PKP2 (plakophilin 2) p.His773AlafsX8 iPSC-CM model of ACM. CONCLUSIONS: We conclude that TAX1BP3 is associated with rare autosomal recessive ACM through TRPV4-mediated Ca 2+ leak from RyR2. Further, TRPV4 current inhibition has the potential to be a new therapeutic target for ACM.

21 October 2025 in Circulation
Verified
Journal Article
Closed access
FLFujian Lu
Fujian Lu
ZWZexuan Wu
Zexuan Wu
SCShaopeng Chi
Shaopeng Chi
YWYangong Wang
Yangong Wang
APAnna Ponek
Anna Ponek
WPWilliam Pu
William Pu

28 February 2025 in ACS Sensors
Verified
Journal Article
Closed access
ZXZhen Xu
Zhen Xu
APAnna Ponek
Anna Ponek
JTJordan Thomas
Jordan Thomas
YQYibing Qyang
Yibing Qyang

17 June 2026 in Communications Biology
Verified
Journal Article
Open access
ZWZexuan Wu
Zexuan Wu
CBCamille Blandin
Camille Blandin
JCJiehui Chen
Jiehui Chen
JLJiajin Li
Jiajin Li
LHLi He
Li He
WPWilliam Pu
William Pu
Diastolic dysfunction, defined by impaired relaxation and increased ventricular stiffness, is central to heart failure with preserved ejection fraction, yet cardiomyocyte-intrinsic mechanisms remain incompletely understood. Here, we show that SORBS2 is a vital component of murine cardiomyocyte adhesion complexes. Its genetic ablation in mice causes progressive diastolic dysfunction with preserved systolic function, accompanied by atrial enlargement and reduced survival. Postnatal cardiomyocyte-directed re-expression of SORBS2 restores diastolic indices and significantly improves longevity. Mechanistically, SORBS2 functions as an integrative scaffold linking adhesome integrity, cytoskeletal remodeling, and calcium homeostasis. SORBS2 deficiency increases microtubule detyrosination, reduces SERCA2 abundance, disrupts dyad-associated organization, which collectively impair active cardiomyocyte relaxation. Concurrently, this deficiency promotes extracellular matrix remodeling and myocardial fibrosis, driving passive ventricular stiffness. Pharmacological inhibition of microtubule detyrosination partially rescues relaxation defects. These findings establish SORBS2 as a key regulator of diastolic function and define a structural axis governing myocardial mechanics, offering potential therapeutic targets.